Fundraising FoxAsset Management Company
Venture capitalMenlo Park · Seed–Series A · 6 people tracked
Also known as ASSET MANAGEMENT VENTURES, LLC
Find your way into Asset Management Company
Each arrow is one introduction. Sign up to fill in the first one.
Ask Matthew R. Patterson to introduce you to Lou Lange
You →Matthew · together at Audentes Therapeutics →Lou
Ask Jamie Chen to introduce you to Rich Simoni
You →Jamie · together at Mozio →Rich
Ask Sam Okafor to introduce you to Skip Fleshman
You →Sam · together at Asset Management Company →Skip
- Melina Mathur3 people can intro you
- Nemariam Mesfin3 people can intro you
- Pitch Johnson3 people can intro you
Sign up to find every way you can get introduced to Asset Management Company
- Your email: who you already know at Asset Management Company, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Asset Management Company team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
AMV invests at the seed and Series A stage in digital health startups, seeking teams with integrity, transparency, and deep market and technical expertise. It looks for defensible companies built on unique technology and data, addressing large markets ripe for disruption, led by passionate domain experts. Drawing on a heritage dating to 1965 and a diversified approach spanning technology, healthcare, and life sciences, AMV takes an active role helping founders navigate early-stage challenges such as hiring, strategic focus, technical development, sales channels, and partnerships. It leverages its network of digital health stakeholders and partners with other top-tier venture firms for later-stage rounds.
Source: firm website, verified Sep 29, 2026.
Team · 6 people
from the firm's website & public directoriesWhat they invest in
from 48 of 61 portfolio companiesHealthtech ×28Digital Health ×20AI & Machine Learning ×16Biotech ×16Medical Devices ×15SaaS ×14Enterprise Software ×7Consumer ×3
HQs:United States×45Japan×1
Who they back
founder profiles across 34 portfolio companiesFounding team size:solo founder×112 founders×173 founders×54+ founders×1
Where their founders studiedfrom 31 founders with education data
Massachusetts Institute of Technology ×3University of California, Berkeley ×3MIT Sloan School of Management ×2Stanford University Graduate School of Business ×2University of Calicut ×2
What their founders studiedfrom 35 founders with field-of-study data
Life Sciences ×11Computer Science ×10Engineering ×8Chemistry ×4Finance & Accounting ×3Medicine ×3Business & Management ×2Design & Architecture ×2
Where their founders worked beforefrom 37 founders with career history
Massachusetts Institute of Technology ×2University of Virginia ×2
10 founders hold a PhD · 4 hold an MBA (of 35 with degree data)
Investments · 61 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12021 · 22019 · 22018 · 12017 · 12016 · 12015 · 42014 · 72013 · 12007 · 122 dated
Amgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis.
AI & Machine LearningBiotechHealthtechMedical DevicesThousand Oaks, US
William K. Bowes(Founder)George B. Rathmann(First CEO)David Piacquad(Executive Officer)Brian M. McNamee(Executive Officer)inRobert A. Bradway(Executive Officer, Director)David J. Scott(Executive Officer)
Co-investorsBOMBoulder VenturesMayfield FundRidgeback CapitalSunstone Capital
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, US
Riley Ennis(Co-Founder and Chief Product Officer)inCharles Roberts(Director)inGabriel Otte(Director)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)
Co-investorsRA CapitalAgent CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAverin Capital+14 more
Ooma Direct Routing for Microsoft Teams enables organizations to connect their Teams collaboration platform to the Public Switched Telephone Network for voice calling.
Cloud ComputingConsumerEnterprise SoftwareFuture of WorkSaaSPalo Alto, US
Andrew FrameinSpencer Jackson(Executive Officer)inEric B. Stang(President and Chief Executive Officer)inShig Hamamatsu(Senior Vice President and Chief Financial Officer)inJenny C. Yeh(Senior Vice President and Chief Legal Officer)inNamrata Sabharwal(Chief Accounting Officer)in
Co-investorsWI Harper Group
Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US
Bill Fawcett(Co-founder)Natalie Wisniewski(Executive Officer, Director)inBill McMillan(Co-Founder, CSO & Head of Research)Ben Healy(CEO)Ben Hwang(Chairman & CEO)in
BoardQianye Karen Liu(Director)
Co-investors3E Bioventures CapitalAtinum Investment Co. Ltd.Sand Hill AngelsBioVentures
Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.
BiotechDeep TechSemiconductorsSouth San Francisco, US
William Charles Banyai(Executive Officer, Director, Promoter)Bill James Peck(Executive Officer, Promoter)Emily Leproust(Founder)inEmily Leproust, PhD(CEO and Co-Founder of Twist)Patrick Finn(President and Chief Operating Officer)inAdam Laponis(Chief Financial Officer)in
Co-investors+ND Capital3E Bioventures CapitalARCH Venture PartnersATEL VenturesBay City CapitalBlack Opal Ventures+10 more
3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets.
AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US
K. Christopher GarciaMarvin Gee(Founder)in
Co-investorsCollaborative FundCRV (Charles River Ventures)Westlake Village BioPartnersMenlo VenturesOS FundStarlight Ventures+1 more
Aavia is a mobile app that helps people with ovaries track and understand how their hormones impact their health, mood, and productivity.
ConsumerDigital HealthFemTechHealthtechWellness & Fitness
Aagya Mathur(Co-founder & CEO)inAya Suzuki(Co-founder & Head of Design & Experience)inAlexis Wong(Cofounder)
Co-investors37 AngelsBantam GroupDorm RoomPopstar VenturesSeven Seven SixAsset Management Ventures+5 more
Amygdala Neurosciences is a biopharmaceutical company developing oral medications to treat alcohol and substance use disorders by targeting the ALDH2 enzyme.
BiotechHealthtechMedical DevicesSan Francisco, US
Adrienne M. MacMillan(Executive Officer)Ivan F. Diamond(Executive Officer, Director)
BoardLouis G. Lange(Director)Mack C. Mitchell, Jr.(Director)
Array Insights develops software for clinical trial optimization using federated learning and blockchain technologies, serving healthcare organizations and researchers seeking to improve medical collaboration and trial efficiency.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechCambridge, US
Anne Kim(Co-Founder and CEO)inManolis Kellis(Founder)in
Co-investorsArgon VenturesDorm RoomJoint EffectsMozilla VenturesThe E14 FundTwo Lanterns Venture Partners
Arterys provides AI clinical applications for medical imaging that integrate directly into existing PACS and EHR systems to assist physicians with diagnosis and treatment decisions.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Fabien Beckers(Executive Officer, Director)John Axerio-Cilies(Executive Officer, Director)
BoardRobert Brownell(Director)Steve Dow(Director)
Co-investorsEmergent Medical Partners, LLPKhosla VenturesNorwich VenturesRevelation PartnersTemasek
Enterprise networking (Wi-Fi, switches, SD-WAN) with cloud-managed security for campuses & branches
Co-investorsAmplify PartnersArtis VenturesCervinGolub GrowthICCP Venture PartnersiGlobe Partners+12 more
BiotechSan Francisco, US
Matthew Patterson(Executive Officer, Director)in
BoardJonathan Silverstein(Director)inSteve Squinto(Director)inKush Parmar(Director)inJonathan Leff(Director)Thomas Woiwode(Director)
Co-investorsRA CapitalvenBio Partners5AM VenturesDeerfield Management CompanyOrbiMedVenrock
Autonomize builds an AI operating layer for healthcare enterprises that structures unstructured data, grounds decisions in clinical and policy evidence, and orchestrates workflows through healthcare-native AI agents working alongside human experts.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechAustin, US
Ganesh Padmanabhan(Executive Officer, Director)inKris Nair(Executive Officer, Director)in
BoardMike Spadafore(Director)inDavid Fleshman(Director)
Co-investorsATX Venture PartnersLoop VCTau VenturesAsset Management Ventures
Basys.ai provides healthcare AI solutions, leveraging data science and machine learning to improve healthcare delivery and operations.
AI & Machine LearningDigital HealthHealthtechLinthicum, US
Amber Nigam(CEO)inJohn(Founder)in
BoardMichael Davis(Chairman)
Co-investorsCeltic House Asia PartnersChaac VenturesNina CapitalTwo Lanterns Venture Partners
Benefitter is a sales enablement software for insurance brokers that provides quoting, enrollment, and client management tools.
InsurTechSaaSSales Tech
Biogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology.
BiotechMedical Devices
Co-investorsAlpha Wave GlobalRiverVest Venture Partners
Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses.
BiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US
George B. Rathmann(First CEO)
BoardWilliam K. Bowes
Co-investorsBOMCWRU Technology VenturesMayfield FundUS Venture PartnersYsios Capital
Biopharmaceutical developer of tumor-selective PARP inhibitor cancer therapies, acquired by Sanofi-aventis in 2009.
Co-investorsAisling CapitalCanaan PartnersKleiner PerkinsSPRINGROCK VENTURESVantagePoint Capital PartnersDomain Associates
Synopsys provides design automation tools and intellectual property for semiconductor and electronics companies to develop smart, connected devices.
Developer ToolsEnterprise SoftwareSemiconductorsBurlington, US
Doug Levin(Founder)Aart de Geus(Founder)inStephen N. Gregorio(Executive Officer)Philip B. Granof(Executive Officer)William NMN Ledingham(Executive Officer)Norman L. Shipley(Executive Officer, Director)
Co-investorsBrightspark VenturesCrosslink CapitalDataTribeDifferential VenturesF-Prime CapitalFrancisco Partners+10 more
Unable to determine company information; page contains only placeholder Lorem ipsum text.
AI & Machine LearningDigital HealthHealthtechPittsburgh, US
Gilan El Saadawi(Executive Officer, Director, Promoter)Betsy Castillo(Head of Clinical Data Abstraction)inMichael Finke(Director)Brenton Burns(Director)Scot Stevens(Director)Aaron Brauser(Executive Officer, Director, Promoter)
Co-investorsCU Healthcare Innovation FundFrist Cressey VenturesHealthy VenturesKatalyst VenturesKatalyst.VenturesLife Sciences Greenhouse Investments+8 more
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
BiotechHealthtechMedical DevicesDurham, US
Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)
Co-investorsAisling CapitalAlta PartnersCanaan PartnersFrazier Life SciencesPappas CapitalSanderling Ventures
Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries.
BiotechDigital HealthHealthtechMedical DevicesFoster City, US
Lou Lange(Founder)Michael L. Riordan(Founder)inDaniel O'Dayin
Co-investorsAisling CapitalFrazier Life SciencesKleiner PerkinsLongitude CapitalLumira VenturesMenlo Ventures+5 more
Decent is a health insurance brokerage that quotes and compares employer health coverage options — including fully insured plans, PEOs, ICHRA, QSEHRA, level-funded, and self-funded arrangements — based on a company's census.
FintechHealthtechHR TechInsurTechSan Francisco, US
Nick Soman(Founder/CEO)inAndrew Budker(Founder/CTO)in
Co-investorsBuckhill CapitalDigital Currency GroupHealthy VenturesMenlo VenturesMouro CapitalQED Investors+3 more
Endless Health provides an all-in-one platform and strategic support for wellness professionals to launch and scale preventive health practices, combining precision lab testing, practice management software, and personalized coaching infrastructure.
HealthtechSaaSWellness & FitnessAustin, US
Cooper Galvin(Executive Officer, Director)
Co-investorsNext Coast VenturesAntlerAsset Management Ventures
Biopharma developing HDL-C regulating therapies; listed 2000.
BiotechAnn Arbor, US
Roger S. Newton(Director)inTim M. Mayleben(Executive Officer, Director)
BoardDaniel Janney(Director)Dov A. Goldstein(Director)Nicole Vitullo(Director)inPatrick Enright(Director)in
Co-investorsAisling CapitalAlta PartnersArboretum VenturesARCHIMED JapanCanaan PartnersHealthCap+3 more
Evidation collects and analyzes real-world health data from millions of community members to enable clinical research and health programs across various medical conditions.
BiotechData & InfrastructureDigital HealthHealthtechSan Francisco, US
Christine Lemke(Executive Officer, Director)inDeborah Kilpatrick(Executive Officer, Director)Leslie Oley Wilberforcein
BoardDavid Fleshman(Director)Rowan Chapman(Director)in
Co-investorsB Capital GroupB4 CapitalCross Creek AdvisorsDementia Discovery FundFresco CapitalG Squared+6 more
.jpeg){kind=logo}
Genoa Healthcare operates full-service pharmacies located inside mental health and community clinics, offering medication management for people with complex needs.
Digital HealthHealthtechMedical DevicesMental HealthWellness & Fitness
Co-investorsAdvent InternationalBPOCShumway CapitalWonder VenturesiSeed VenturesRock Health+1 more
Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings.
BiotechDigital HealthMedical DevicesBrisbane, US
Carlos A. Schuler(Executive Officer, Director)inJohn S. Patton(Executive Officer, Director)inRangachari Narasimhan(Executive Officer, Director)Grace Colon(Executive Officer, Director)inMiller Samantha(Executive Officer)
BoardMcCarthy Reenie(Director)
Co-investorsHealthCapSofinnova VenturesDeerfield Management Company
Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.
BiotechDeep TechMedical DevicesCulver City, US
James Heath(Director)Leroy Hood(Director)Andreas Jurgeit(Director)inHeather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Darren Cai(Director)
Co-investorsLegend CapitalM VenturesAsset Management Ventures
Keepsafe provides privacy and security apps with AES-256 encryption to protect personal content on user devices.
ConsumerCybersecurityUnited States, US
Philipp Berner(Director)inZouhair Belkoura(Executive Officer, Director)in
BoardMichael Maples, Jr.(Director)Masanari Arai(Director)Nuno Goncalves Pedro(Director)Richard Simoni(Director)
Co-investorsChamaeleonFloodgateMcKinsey & Company
Kii provides a backend platform for developing, scaling, and managing mobile and IoT applications with integrated analytics, push notifications, and social features.
Cloud ComputingEnterprise SoftwareIoTSaaSTokyo, JP
Masanari Arai(Founder)inNaoshi Suzuki(Founder)in
Co-investorsCisco InvestmentsKatalyst VenturesKatalyst.Ventures
Lark develops an AI-powered health coaching platform that delivers personalized support for chronic disease prevention and management through 24/7 text-based conversations and integration with smart health devices.
AI & Machine LearningDigital HealthHealthtechMountain View, US
Co-investorsAlpha Intelligence CapitalIPD CapitalJoyance PartnersKing River CapitalOlive Tree CapitalSamsung Next+7 more
LiquidM provides advertising technology solutions including curation platforms, ad enhancements, and sustainability-focused offerings for digital media campaigns.
AdTechMarketing TechSan Francisco, US
Christof Wittig(Executive Officer, Director)inAnne Dorman(Executive Officer)
BoardChristian Nagel(Director)
Mightier develops technology to help children build emotional regulation and resilience skills.
Digital HealthEdTechHealthtechMental Health
Co-investorsDigiTx Partners LLCEastward Capital PartnersFounder CollectiveGutbrain VenturesSony Ventures Corporation
Modern Campus provides software solutions for higher education institutions to attract, engage, and retain students throughout their learning and career development journey.
EdTechEnterprise SoftwareSaaS
Reuben Pressman
Co-investors500 GlobalBessemer Venture Partners
Mozio operates a ground transportation aggregation platform connecting 3,000+ transport providers with travelers and travel businesses across 180 countries.
B2B MarketplacesSaaSTravel & HospitalityNew York, US
David Litwak(Founder)inJoseph Metzinger(Founder)in
BoardRichard Simoni(Director)
Co-investorsHOWZAT PartnersJetBlue VenturesSKY VCAlpaca VC
HPE subsidiary building all-flash and hybrid flash storage arrays with InfoSight predictive analytics for data centers.
Spring, US
Co-investorsAmplify PartnersArtis VenturesiGlobe PartnersKleiner PerkinsMenlo VenturesNew Enterprise Associates (NEA)+7 more
Nuance creates software products, including healthcare solutions for clinical documentation, speech recognition, and virtual assistants.
AI & Machine LearningHealthtechSaaS
Co-investorsMutual Capital PartnersRembrandt Venture PartnersUS Venture PartnersAccelGoldman SachsLightspeed Venture Partners+1 more
Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information.
AI & Machine LearningDigital HealthHealthtechCambridge, US
Maya R. Said(Founder and CEO)inOsama Rahma(Founder)inMaya R. Said, Sc.D.(Founder and CEO)
BoardAndrea Jackson(Director)inDavid Fleshman(Director)David Auckland(Director)
Co-investorsHealthX VenturesSierra VenturesAsset Management VenturesNorthpond Ventures
Pluto aggregates fragmented medical, insurance, and social determinants data from US health systems and applies AI-driven clinical intelligence to identify care gaps and coordinate delivery of preventive care, screenings, and clinical trial enrollment.
AI & Machine LearningDigital HealthHealthtech
Co-investors1843 CapitalSierra Ventures
Properly provides vacation rental management tools and services for hosts, including self-service platforms and full property management operations across 45+ countries.
PropTechSaaS
Co-investorsFJ LabsMachina VenturesThink+ Ventures Management, LlcAlleyCorpBain Capital VenturesGolden Ventures+4 more
Professional social network for active military and veterans.
Middleton, US
Yinon Weiss(Director)Aaron Kletzing(Director)Jennifer Ranuado(Executive Officer)David Gowel(Executive Officer, Director)in
BoardMark Perutz(Director)Andrew L. Ross(Director)
Co-investorsDBL Partners
GE Healthcare provides AI-enabled medical devices and diagnostic solutions for healthcare providers worldwide, helping clinicians improve diagnostic accuracy and clinical decision-making.
AI & Machine LearningHealthtechMedical Devices
Co-investorsJSD Capital, LLCKortschak Investments L.P.
Reify Health operates clinical trial technology and services to accelerate the delivery of new therapies to patients.
Digital HealthHealthtechSaaSBoston, Ma, US
Ralph Passarella(Founder)inMichael Lin(Mr. Lin is the Secretary of the Issuer.)
BoardNeeraj Agrawal(Director)inDavid Fleshman(Director)Mark Fernandes(Director)in
Co-investorsBattery VenturesCoatue ManagementEnsemble LabsICONIQLeo Capital VenturesSierra Ventures
EdTechEnterprise SoftwareSaaSAlexandria, US
Brian Kathman(Executive Officer, Director)Ralph Joseph Passarella(Director)in
BoardRobert Proctor(Director)
Co-investorsFigure 8 InvestmentsNew Markets Venture PartnersThe Riverside Company
SubjectWell operates a patient network that links individuals to clinical trials and connects them with healthcare providers and pharmaceutical sponsors.
BiotechDigital HealthHealthtech
Co-investorsATPGeekdomHealthy VenturesMartin VenturesWindham Capital PartnersAsset Management Ventures
UniKey provides mobile credential technology for lock and access control manufacturers, enabling integration with Apple Wallet, Google Wallet, and Bluetooth.
HardwareIoTSaaSOrlando, US
PHIL DUMAS(Executive Officer, Director)in
BoardJOHN FRANKEL(Director)inRICHARD SIMONI(Director)MANUEL KADRE(Director)STEVEN FISKE(Director)in
Co-investorsAkkadian VenturesDaniel GutenbergFf Venture CapitalKombo VenturesLauder PartnersRealization Capital Partners+2 more
Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US
Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in
BoardVasudev Bailey(Director)in
Co-investorsAbstract VenturesArtis VenturesBetter Ventures Central LlcBlue Bear VenturesColorcon VenturesDroia Ventures+8 more
.png)
Welkin Health provides a healthcare customer relationship management platform that enables organizations to design and deliver personalized, longitudinal care solutions for patients with chronic, preventative, and follow-up conditions.
Digital HealthEnterprise SoftwareHealthtechSaaSCalifornia, US
Co-investorsGreat Oaks Venture CapitalThrive Capital
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.
AI & Machine LearningDigital HealthHealthtechBaltimore, US
Ryan Sysko(Executive Officer, Director)inSuzanne Clough(Executive Officer)inKevin McRaith(President and CEO)inAnand Iyer(Chief AI Officer)inChris Bergstrom(Executive Officer)in
BoardTerry Lierman(Director)
Co-investorsMerck Global Health Innovation FundSamsung VenturesDigiTx Partners LLCExcel Venture ManagementMSD Global Health Innovation FundTCP Venture Capital+2 more
Womply built software for small businesses including CRM, marketing, and reputation management tools; it later processed Paycheck Protection Program applications for sole proprietors and 1099 workers through a technology platform provided to SBA-approved lenders.
Data & InfrastructureFintechMedia & EntertainmentSaaSSan Francisco, US
Toby Scammell(Founder & CEO)Jeremy RichardsonCory C.(Founder)in
Co-investors500 GlobalEnspire CapitalMerus CapitalRising TideSageview CapitalStreamlined Ventures+1 more
Yiftee provides eGift Cards and its Community Card, a single card redeemable across a curated network of local merchants, to keep consumer spending within local business economies.
FintechImpact & Social GoodRetail TechSaaS
Co-investorsTransPacific Venture PartnersMohr Davidow Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Boole and BabbageCoherent LaserEvidationHealthTapPlutoPMC-SierraSensOmicsTandem Computers
Exits · 10
5 IPOs · 5 acquisitions · showing 8AmgenNASDAQ: AMGNFreenomeNASDAQ: FRNMOomaNYSE: OOMAProfusaNASDAQ: PFSATwist BioscienceNASDAQ: TWSTArubaacq. by Hewlett-PackardBioVexacq. by AmgenSignal Vineacq. by Modern Campus
Portfolio news
latest coverage across their companies
Welkin · trysignalbase.com · Jun 30, 2026
Womply · womply.com · Jun 25, 2026
Esperion Therapeutics · stocktitan.net · Jun 8, 2026
Unnatural Products · finance.yahoo.com · Mar 16, 2026
Profusa · globenewswire.com · Feb 19, 2026
Outcomes4Me · finsmes.com · May 30, 2025
Frequently asked questions
- How many investments has Asset Management Company made?
- Asset Management Company has 61 tracked investments, 10 of which have exited.
- What stage does Asset Management Company invest at?
- Asset Management Company invests at the Seed, Series A stages.
- What is Asset Management Company's typical check size?
- Asset Management Company typically writes checks of $500K – $2M.
- What sectors does Asset Management Company focus on?
- Asset Management Company focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech.
- Where is Asset Management Company located?
- Asset Management Company is headquartered in Menlo Park, US.
- Who does Asset Management Company co-invest with?
- Asset Management Company most often shares deals with Kleiner Perkins, Aisling Capital, Artis Ventures, among 210 tracked co-investors.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.